Study to Evaluate Safety, Tolerability and Efficacy of GSK2330811 in Crohn's Disease

Stopped Internal sponsor decision to terminate project in Crohn's disease due to potential narrow therapeutic window. No subjects were enrolled

Conditions

• Crohns Disease
• Crohn's Disease

Interventions

• DRUG: GSK2330811
• DRUG: Placebo

Sponsor

GlaxoSmithKline